Results 81 to 90 of about 16,555,945 (165)
Chronic lymphocytic leukemia: from molecular pathogenesis to novel therapeutic strategies
Chronic lymphocytic leukemia is a well-defined lymphoid neoplasm with very heterogeneous biological and clinical behavior. The last decade has been remarkably fruitful in novel findings elucidating multiple aspects of the pathogenesis of the disease ...
Julio Delgado +3 more
doaj +1 more source
EHA Guidelines on management of chronic lymphocytic leukemia and Richter transformation
Abstract Previous editions of the European guidelines for the management of chronic lymphocytic leukemia (CLL) were developed by experts in CLL under the auspices of the European Society for Medical Oncology (ESMO). These previous editions have served as a reference text for many physicians caring for patients with CLL.
Barbara Eichhorst +13 more
wiley +1 more source
Image_3_CD20+ T cells in monoclonal B cell lymphocytosis and chronic lymphocytic leukemia: frequency, phenotype and association with disease progression.pdf [PDF]
IntroductionIn monoclonal B cell lymphocytosis (MBL) and chronic lymphocytic leukemia (CLL), the expansion of malignant B cells disrupts the normal homeostasis and interactions between B cells and T cells, leading to immune dysregulation.
Sandra Silva (3520043) +35 more
core +1 more source
Persistent polyclonal B lymphocytosis with multiple bcl-2/IgH rearrangements: a benign disorder
The appearance of a chronic B lymphocytosis is usually associated with the existence of an underlying monoclonal malignant condition. However, a few cases of persistent polyclonal B cell lymphocytosis (PPBL), presented in young asymptomatic women with an
E Granados +8 more
doaj
Image_4_CD20+ T cells in monoclonal B cell lymphocytosis and chronic lymphocytic leukemia: frequency, phenotype and association with disease progression.pdf [PDF]
IntroductionIn monoclonal B cell lymphocytosis (MBL) and chronic lymphocytic leukemia (CLL), the expansion of malignant B cells disrupts the normal homeostasis and interactions between B cells and T cells, leading to immune dysregulation.
Sandra Silva (3520043) +35 more
core +1 more source
Recent improvements in molecular sub typing of Non Hodgkin’s lymphomashave resulted in targeted therapies becoming incorporated into treatmentparadigms.
Nolan, David Francis Luke
core +1 more source
HemaSphere, Volume 10, Issue 9, September 2026.
Gabriela Mladonicka Pavlasova +13 more
wiley +1 more source
Impact Immune dysregulation is thought to contribute to chronic lymphocytic leukemia (CLL) risk, but biological mechanisms are unclear. We discovered that increased serum levels of B-cell activating factor (BAFF), an important regulator of B-cell ...
Eleanor Frost +5 more
doaj +1 more source
A Unique Hairy Cell Leukemia Variant
A 65-year-old woman presented with easy bruising, left upper quadrant pain, decreased appetite, and weight loss. She had splenomegaly and lymphocytosis (lymphocyte count of 11.6 × 109/l), with remarkably abnormal appearing morphology.
Charles Jian, Cyrus C. Hsia
doaj +1 more source
Asymptomatic T prolymphocytic leukemia: case report and literature review [PDF]
T-cell prolymphocytic leukemia is a rare and aggressive mature T-cell malignancy that usually presents with marked lymphocytosis, hepatosplenomegaly, lymphadenopathy, and B symptoms.
Luiz Frederico Bezerra Honorato Junior +11 more
doaj +1 more source

